anti-EGFR fluorescence imaging agent ABY-029
Term · Oncology and biomedicine · MLC-T-ONC-010590
A fluorescence imaging and contrast agent composed of an epidermal growth factor receptor (EGFR)-targeting affibody tracer molecule and labeled, through maleimide, with a near-infrared (NIR) fluorescent probe, IRDye 800CW, with potential use in the imaging of EGFR-overexpressing cells. Upon administration, ABY-029 targets and binds to EGFR-overexpressing tumor cells. Upon fluorescent imaging, the fluorescent dye can be visualized and EGFR-positive tumor cells can be detected.
| Identifier | MLC-T-ONC-010590 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ABY-029 trifluoroacetate salt; IRDye 800CW maleimide-labeled affibody peptide; fluorescently-labeled Anti-EGFR affibody molecule ABY-029 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010590",
"term": "anti-EGFR fluorescence imaging agent ABY-029",
"field": "Oncology and biomedicine",
"definition": "A fluorescence imaging and contrast agent composed of an epidermal growth factor receptor (EGFR)-targeting affibody tracer molecule and labeled, through maleimide, with a near-infrared (NIR) fluorescent probe, IRDye 800CW, with potential use in the imaging of EGFR-overexpressing cells. Upon administration, ABY-029 targets and binds to EGFR-overexpressing tumor cells. Upon fluorescent imaging, the fluorescent dye can be visualized and EGFR-positive tumor cells can be detected.",
"synonyms": [
"ABY-029 trifluoroacetate salt",
"IRDye 800CW maleimide-labeled affibody peptide",
"fluorescently-labeled Anti-EGFR affibody molecule ABY-029"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-egfr-fluorescence-imaging-agent-aby-029/"
}
Record 1,686 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.